[December 4-8, 2011]
DNDi participated with presentations on the Leishmaniasis East Africa Platform and on Chagas disease, as well as with several posters and a DNDi booth.
[December 4-8, 2011]
[December 2, 2011]
‘Moving Innovation to Access for Neglected Patients’
Rio de Janeiro, Brazil
This year marks nearly a decade of progress since the foundations for DNDi were set forth at a remarkable meeting in Rio in 2002. Just nine years later, we come together again to review DNDi’s progress in bringing new treatments to neglected patients as well as to evaluate the main challenges in access to new tools.
[December 1st, 2011]
Rio de Janeiro
The meeting “Artesunate-Mefloquine (ASMQ) Fixed-Dose Combination (FDC), an additional tool in the armamentarium to control malaria in Latin-America” was held in parallel with DNDi‘s annual partners’ meeting in Rio de Janeiro.
[October 23-26, 2011]
DNDi co-organized a session on Product Development for Neglected Patients and took part to the Innovation session.
Check here for the detailed presentation of the symposia, with speakers.
[October 9 – 12, 2011]
Addis Ababa, Ethiopia
DNDi attended the Forum whose theme for 2011 was “Strengthening Research Partnerships for Better Health and Sustainable Development”
[October 3-6, 2011]
At this major European conference, DNDi organized symposia on kinetoplatid diseases and VL-HIV co-infection. Bernard Pécoul spoke in a plenary session (video accessible here) on ‘The Science of Elimination’.
[Sept 21-23, 2011]
All key LEAP platform members gathered to share recent progress in the field of Visceral Leishmaniasis.
[September 12-16, 2011]
DNDi attended the 31st Conference of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) in the session on HAT chemotherapy.
[July 17-20, 2011]
With the expansion of its portfolio to paediatric HIV, DNDi attended the IAS conference to advocate on R&D needs for better adapted drugs for infants
[July 8-10, 2011]
DNDi attended the firsts NTD meeting of ISID in the following sessions: “Developing the Tools Needed to Fight NTDs” and “Essential Elements: Drug Donations and Nongovernmental Development Programs”
[January 24, 2011]
Drugs for Neglected Diseases initiative (DNDi) and Cipla, jointly with Vimal, organised a symposium to discuss the use of Artemisin Combination Therapy in Myanmar.